Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Quality of life results of the randomized phase II AIO-NEONAX trial.

Autor: Buchholz, Sina, Ettrich, Thomas Jens, Uhl, Waldemar, Kornmann, Marko, Algül, Hana, Friess, Helmut, Koenig, Alexander, Gallmeier, Eike, Lutz, Manfred P., Wille, Kai, Schimanski, Carl Christoph, Kunzmann, Volker, Geissler, Michael, Waldschmidt, Dirk, Daum, Severin, Perkhofer, Lukas, Reinacher-Schick, Anke C., Seufferlein, Thomas
Zdroj: Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p694-694, 1p
Databáze: Supplemental Index